Regeneron Pharmaceuticals, Inc.

NasdaqGS:REGN

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

🔍 Research & Consulting

💉 Vaccines

Location

United States

Market Cap

USD 57.86 B

Share Price

USD 545.94

Avg Daily Volume

1,200,535

Change (1 day)

-3.03%

Change (1 year)

-51.74%

Change (YTD)

-23.36%

Regeneron Pharmaceuticals, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2025: USD 4.74 B

Regeneron Pharmaceuticals, Inc. Operating Cash Flow is USD 4.74 B for the Trailing 12 Months (TTM) ending June 30, 2025, a 16.53% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Regeneron Pharmaceuticals, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2024 was USD 4.07 B, a -14.10% change year over year.
Regeneron Pharmaceuticals, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2023 was USD 4.74 B, a -43.93% change year over year.
Regeneron Pharmaceuticals, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2022 was USD 8.45 B, a 272.03% change year over year.
Regeneron Pharmaceuticals, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2021 was USD 2.27 B, a -23.92% change year over year.